Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both epicardial vessels and microvasculature and remains a leading cause of posttransplant morbidity and mortality. This study ...
Journal of Nuclear Medicine January 2025, jnumed.124.268275; DOI: https://doi.org/10.2967/jnumed.124.268275 ...
Journal of Nuclear Medicine January 2025, jnumed.124.267769; DOI: https://doi.org/10.2967/jnumed.124.267769 ...
Journal of Nuclear Medicine January 2025, jnumed.124.269268; DOI: https://doi.org/10.2967/jnumed.124.269268 ...
Objectives [11C]JNJ-42491293 is a novel PET tracer for the metabotropic glutamate receptor subtype 2 (mGluR2) targeting an allosteric site as a potential therapeutic mechanism. The mGluR2 is ...
Journal of Nuclear Medicine January 2025, jnumed.124.268578; DOI: https://doi.org/10.2967/jnumed.124.268578 ...
Journal of Nuclear Medicine January 2025, jnumed.124.268998; DOI: https://doi.org/10.2967/jnumed.124.268998 ...
Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...
Journal of Nuclear Medicine January 2025, jnumed.124.268233; DOI: https://doi.org/10.2967/jnumed.124.268233 ...
Journal of Nuclear Medicine January 2025, jnumed.124.268365; DOI: https://doi.org/10.2967/jnumed.124.268365 ...
Journal of Nuclear Medicine January 2025, jnumed.124.268638; DOI: https://doi.org/10.2967/jnumed.124.268638 ...